|Free Dividend Report|
|Stock Splits Calendar|
|ACOR Historical Stock Prices|
|Preferred Stock Newsletter|
|ACOR Options Chain|
|Stock Message Boards|
Acorda Therapeutics (ACOR) has the following price history information. Looking back at ACOR historical stock prices for the last five trading days, on November 22, 2023, ACOR opened at $9.80, traded as high as $9.80 and as low as $9.80, and closed at $9.80. Trading volume was a total of 400 shares. On November 24, 2023, ACOR opened at $9.77, traded as high as $9.77 and as low as $9.77, and closed at $9.77. Trading volume was a total of 400 shares. On November 27, 2023, ACOR opened at $9.80, traded as high as $10.98 and as low as $9.60, and closed at $10.45. Trading volume was a total of 8.00K shares. On November 28, 2023, ACOR opened at $10.45, traded as high as $10.49 and as low as $10.38, and closed at $10.49. Trading volume was a total of 5.40K shares. On November 29, 2023, ACOR opened at $10.44, traded as high as $10.44 and as low as $9.71, and closed at $10.08. Trading volume was a total of 1.20K shares.
ACOR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acorda Therapeutics shares, starting with a $10,000 purchase of ACOR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-45.08%|
|ACOR Historical Price Range|
|About Acorda Therapeutics|
|Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Co. markets Inbrija (levodopa inhalation powder), which is approved for intermittent treatment of episodic motor fluctuations, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija utilizes Co.'s ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. Co. also markets Ampyra (dalfampridine) extended release tablets, 10 mg for improving walking in patients with multiple sclerosis. Ampyra is marketed as Fampyra outside the U.S.|
|ACOR Historical Closing Prices|
|Healthcare Historical Prices|
|ACOR is categorized under the Healthcare sector; below are some other companies in the same sector:
ACRS Historical Stock Prices
Also explore: ACOR shares outstanding history
ACOR Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights ReservedNothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.